Comparison

Cimdelirsen (sodium) European Partner

Item no. HY-153485A-1ea
Manufacturer MedChem Express
CASRN 2131025-83-5
Amount 1 ea
Category
Type Inhibitors
Specific against other
Formula C296H415N83Na20O152P20S15
Citations [1]Bhanot S, Fleseriu M, Geary R, et al. OR27-4 Placebo-Controlled and Open-Label Extension Study of a Novel Hepatic-Targeted Antisense Cimdelirsen (IONIS-GHR-LRx) Under Investigation in Acromegaly Patients. J Endocr Soc. 2022;6(Suppl 1):A526.
Smiles [Cimdelirsen (sodium)]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias ISIS 766720 (sodium); IONIS-GHR-LRx (sodium)
Available
Product Description
Cimdelirsen is a novel, ligand-conjugated, hepatic-targeted investigative antisense oligonucleotide designed to reduce growth hormone receptor (GHr) synthesis, thereby inhibiting deleterious effects of growth hormone (GH) hypersecretion and reducing circulating insulin-like growth factor-1 (IGF-1) levels in acromegaly patients.
Shipping
Room temperature
MolecularWeight
9128.16
Clinical Information
Phase 2
Manufacturers Research Area
Others
Solubility
10 mM in H2O
Target
Small Interfering RNA (siRNA)
Manufacturers Target
Small Interfering RNA (siRNA)
Manufacturers Pathway
Epigenetics
Manufacturers Product type
Oligonucleotides

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close